Pharmacology

breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17

breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17

breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17

serotonin reuptake inhibitors, SSRIs, depression, pregnancy, congenital anomalies, septal heart defects, anencephaly, limb reduction defects, Helsinki University Central Hospital and HUSLAB, National Institute for Health and Welfare, Nordic School of Public Health, fetal anomalies, paroxetine, citalopram, fetal alcohol spectrum disorders serotonin reuptake inhibitors, SSRIs, depression, pregnancy, congenital anomalies, septal heart defects, anencephaly, limb reduction defects, Helsinki University Central Hospital and HUSLAB, National Institute for Health and Welfare, Nordic School of Public Health, fetal anomalies, paroxetine, citalopram, fetal alcohol spectrum disorders

serotonin reuptake inhibitors, SSRIs, depression, pregnancy, congenital anomalies, septal heart defects, anencephaly, limb reduction defects, Helsinki University Central Hospital and HUSLAB, National Institute for Health and Welfare, Nordic School of Public Health, fetal anomalies, paroxetine, citalopram, fetal alcohol spectrum disorders serotonin reuptake inhibitors, SSRIs, depression, pregnancy, congenital anomalies, septal heart defects, anencephaly, limb reduction defects, Helsinki University Central Hospital and HUSLAB, National Institute for Health and Welfare, Nordic School of Public Health, fetal anomalies, paroxetine, citalopram, fetal alcohol spectrum disorders

serotonin reuptake inhibitors, SSRIs, depression, pregnancy, congenital anomalies, septal heart defects, anencephaly, limb reduction defects, Helsinki University Central Hospital and HUSLAB, National Institute for Health and Welfare, Nordic School of Public Health, fetal anomalies, paroxetine, citalopram, fetal alcohol spectrum disorders serotonin reuptake inhibitors, SSRIs, depression, pregnancy, congenital anomalies, septal heart defects, anencephaly, limb reduction defects, Helsinki University Central Hospital and HUSLAB, National Institute for Health and Welfare, Nordic School of Public Health, fetal anomalies, paroxetine, citalopram, fetal alcohol spectrum disorders

cardiac disease, tiotropium mist inhalers, chronic obstructive pulmonary disease, COPD, Johns Hopkins University School of Medicine, University of East Anglia, University of Arizona, Wake Forest University School of Medicine, dose-response relationship, pulmonary disease, safetycardiac disease, tiotropium mist inhalers, chronic obstructive pulmonary disease, COPD, Johns Hopkins University School of Medicine, University of East Anglia, University of Arizona, Wake Forest University School of Medicine, dose-response relationship, pulmonary disease, safety

cardiac disease, tiotropium mist inhalers, chronic obstructive pulmonary disease, COPD, Johns Hopkins University School of Medicine, University of East Anglia, University of Arizona, Wake Forest University School of Medicine, dose-response relationship, pulmonary disease, safetycardiac disease, tiotropium mist inhalers, chronic obstructive pulmonary disease, COPD, Johns Hopkins University School of Medicine, University of East Anglia, University of Arizona, Wake Forest University School of Medicine, dose-response relationship, pulmonary disease, safety

cardiac disease, tiotropium mist inhalers, chronic obstructive pulmonary disease, COPD, Johns Hopkins University School of Medicine, University of East Anglia, University of Arizona, Wake Forest University School of Medicine, dose-response relationship, pulmonary disease, safetycardiac disease, tiotropium mist inhalers, chronic obstructive pulmonary disease, COPD, Johns Hopkins University School of Medicine, University of East Anglia, University of Arizona, Wake Forest University School of Medicine, dose-response relationship, pulmonary disease, safety

rheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospitalrheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospital

rheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospitalrheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospital

rheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospitalrheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospital

levothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosislevothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosis

levothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosislevothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosis

levothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosislevothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosis

essential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hbessential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hb

essential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hbessential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hb

essential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hbessential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hb

antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin

antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin

antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin

caffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasoundcaffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasound

caffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasoundcaffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasound

caffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasoundcaffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasound

corticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFAcorticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFA

corticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFAcorticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFA

corticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFAcorticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFA

nonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertensionnonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertension

nonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertensionnonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertension

nonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertensionnonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertension